{"id":"NCT02234310","sponsor":"Bioverativ, a Sanofi company","briefTitle":"Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia B","officialTitle":"An Open-Label, Multicenter Evaluation of the Safety and Efficacy of Recombinant Coagulation Factor IX Fc Fusion Protein (rFIXFc; BIIB029) in the Prevention and Treatment of Bleeding in Previously Untreated Patients With Severe Hemophilia B","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-11-13","primaryCompletion":"2019-08-20","completion":"2019-08-20","firstPosted":"2014-09-09","resultsPosted":"2020-07-31","lastUpdate":"2022-03-25"},"enrollment":33,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia B"],"interventions":[{"type":"BIOLOGICAL","name":"rFIXFc","otherNames":["BIIB029","Alprolix","recombinant coagulation factor IX Fc fusion protein"]}],"arms":[{"label":"Recombinant Coagulation Factor IX Fc Fusion Protein (rFIXFc)","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study was to evaluate the safety of recombinant coagulation factor IX Fc fusion protein (rFIXFc, BIIB029) in previously untreated patients (PUPs) with severe hemophilia B. Secondary objectives were to evaluate the efficacy of rFIXFc in the prevention and treatment of bleeding episodes in PUPs, and to evaluate rFIXFc consumption for prevention and treatment of bleeding episodes in PUPs.","primaryOutcome":{"measure":"Percentage of Participants With Confirmed Inhibitor Development as Measured by the Nijmegen-Modified Bethesda Assay","timeFrame":"Up to 3 years","effectByArm":[{"arm":"Recombinant Coagulation Factor IX Fc Fusion Protein (rFIXFc)","deltaMin":3.03,"sd":null}],"pValues":[]},"eligibility":{"minAge":null,"sex":"MALE","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":12},"locations":{"siteCount":27,"countries":["United States","Australia","Denmark","France","Ireland","Italy","Netherlands","New Zealand","Poland","Sweden","United Kingdom"]},"refs":{"pmids":["38922990","34242387"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":23,"n":33},"commonTop":["Pyrexia","Nasopharyngitis","Upper respiratory tract infection","Fall","Teething"]}}